BC
TRIV

Broadfin Capital’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Broadfin Capital’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,032
Closed -$32K – 104
2015
Q2 		$32K Buy
+6,032
New +$42.8K ﹤0.01% 94

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Broadfin Capital's TRIV Position: Q3 2015 in Review

Broadfin Capital sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2015, closing a stake of 6,032 shares — an estimated $32K sold.

Broadfin Capital first reported a position in TRIV in Q2 2015 and held it in 1 quarter. The position peaked at $32K in Q2 2015. 26 funds tracked by Wall St. Rank hold TRIV as of Q3 2015.

  • Broadfin Capital reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Broadfin Capital sold 6,032 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2015, an estimated $32K.
  • Broadfin Capital first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2015 and held it in 1 quarter.
  • Broadfin Capital's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $32K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2015.

Based on Broadfin Capital's 13F filing for Q3 2015, filed 16 Nov 2015.